Cite

HARVARD Citation

    Prondzynski, M. et al. (2022). Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy. EMBO molecular medicine. 14 (8), p. n/a. [Online]. 
  
Back to record